INTRODUCTION
Acinetobacter baumannii is a major nosocomial pathogen, particularly in the intensive care unit (ICU) setting. This bacterial species is characterized by its resistance to multiple antimicrobial agents, propensity for clonal spread and involvement in numerous hospital outbreaks. Eight A. baumannii international clones (IC 1-8) have been identified. IC 2 is the most widespread and is often associated with carbapenem resistance (1) .
A. baumannii is one of the most commonly isolated multidrug resistant (MDR) pathogens in the University Hospital "Saint Marina" (H1) and Municipal Hospital "Saint Anna" (H2) in Varna, Bulgaria during the last decade. The objective of this study was to investigate the molecular epidemiology of MDR A. baumannii isolates collected from patients in the two hospitals during the period 2005/2007 and 2010/2012 with the aim to identify the predominant clonal lineages circulating in the hospitals and their mechanism of carbapenem resistance.
MATERIAL AND METHODS
A total of 93 nonduplicate MDR isolates of A. baumannii, obtained from patients admitted in ICUs (58%) and surgical wards (42%), were investigated. The isolates were recovered predominantly from wound specimens (46%) and tracheal aspirates (42%). Sixty four isolates were collected in the peri- , bla OXA-51-like , bla IMP , bla VIM , bla NDM ) was performed by PCR (6, 8) .
RESULTS AND DISCUSSION
Twenty six isolates (28%) were imipenem and meropenem resistant and resistant to most of the antibiotics tested, except colistin. One isolate (bla-OXA-58-like positive) demonstrated resistance to imipenem (MIC = 16 µg/ml), but susceptibility to meropenem (MIC = 4 µg/ml). Most isolates were resistant to β-lactams other than carbapenems, including piperacillin -100%; ceftazidime -98.9%; cefepime -97.8% and ampicillin/sulbactam -92.5%, as well as to non-β-lactam antibiotics: gentamicin -91.4%; amikacin -87%; ciprofloxacin -91.4% and trimethoprim/sulfamethoxazole -87%.
In the group of isolates from H2 (n=68), PFGE of the ApaI-digested genomic DNA identified 6 pulsotypes (A-F), two of which were predominant (A, B) ( (Fig. 1) .
Pulsotype B was represented by 22 CS and one CR isolate, all collected during 2005-2007 from Orthopedic surgery, I and II General surgery wards and the ICU. Two environmental isolates (working surfaces and sheets) from the ICU and Orthopedic surgery were found to express identical PFGE pulsotype B as that of the clinical isolates, demonstrating the role of the hospital environment as an important factor for transmission and dissemination of this nosocomial pathogen. Representative isolates for pulsotype B were found to correspond to IC1 (Figure 1) . In 2012 no isolates were found to cluster with IC1. Both dominant clones A and B have spread in parallel among several wards of the hospital during the studied period, indicating nosocomial cross transmission.
Pulsotype D was detected in 9 CS isolates, all recovered from five different wards (ICU, Gynecology, Orthopedic surgery, I and II General surgery wards) but only in 2005. Representative isolates for this pulsotype cluster with IC8 ( Figure 1 ). Isolates belonging to IC8 were not found in 2012.
Pulsotype E was identified in 5 CS isolates, collected from ICU, Orthopedic surgery and II General Surgery ward during the period 2006-2007. Representative isolates of pulsotype E cluster with IC2. Although the first IC2 isolate was recovered in 2006 in Orthopedic surgery, this clone was also detected in 2012 but was already represented by CR A. baumannii isolates. The isolates from H1 (22 CR and 3 CS), recovered predominantly from the surgical ICU (n=23) during the period 2010-2012, also clustered with IC2 (Figure 1 ). Pulsotype C and F from H2 represented single isolates.
All isolates had the intrinsic bla OXA-51-like gene. All CR A. baumannii were found to harbour an acquired bla OXA gene; bla OXA-23-like was detected in twenty six CR isolates and bla OXA-58-like in one CR isolate. bla OXA-58-like was also detected in one CS isolate. 
CONCLUSIONS
This study demonstrates the epidemic and endemic potential of A. baumannii. A total of 70% of the investigated isolates from both hospitals cluster with IC1, 2 and 8, confirming the wide geographical distribution of these epidemic clonal lineages. In 2005-2007, MDR in A. baumannii in H2 was associated with coexistence and intrahospital dissemination of the unique local clone A and with IC1, IC2 and IC8. Clone A and IC2 were found still to persist in 2012. In this regard, the problem of MDR A. baumannii is not only related to the international clonal lineages but also to other successfully disseminated genotypes. In this study, carbapenem resistance in the investigated Bulgarian hospitals, mediated mainly by the acquired OXA-23 carbapenemase, was associated with both persisting hospital clones A and IC2. 
